{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:51:18Z","timestamp":1791186678131,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00218543"],"award-info":[{"award-number":["RS-2023-00218543"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00242443"],"award-info":[{"award-number":["RS-2023-00242443"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2023R1A2C200769911"],"award-info":[{"award-number":["2023R1A2C200769911"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00415347"],"award-info":[{"award-number":["RS-2024-00415347"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) progression is driven by intricate interactions between neoplastic cells and immune populations within the tumor microenvironment (TME), yet the temporal organization of these processes remains insufficiently defined. While tumor-associated macrophages (TAMs), composed of microglia and monocyte-derived macrophages, constitute a major immune population in GBM, microglia play a prominent role in shaping local immunosuppressive niches, thereby limiting cytotoxic lymphocyte infiltration. However, static co-culture models constrain interrogation of dynamic tumor-immune signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized a programmable multi-inlet microfluidic platform that allows sequential, order-specific introduction of immune cells into GBM constructs, enabling controlled interrogation of MG- and natural killer (NK)\u2013mediated interactions under defined temporal conditions. Bulk transcriptomic profiling and single-cell analyses were used to characterize tumor- and immune-associated pathways elicited by distinct temporal configurations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In triculture constructs containing identical populations of GBM cells, microglia, and NK cells, MG-first delivery preferentially activated STAT3-associated immunoregulatory transcriptional programs, whereas NK-first delivery induced cytotoxic and interferon-related gene expression profiles. IL12A expression was selectively increased under NK-first conditions and correlated with immune-active GBM states in patient datasets. STAT3 inhibition reduced MG-associated suppression, increased IL12A expression, and enhanced the response to temozolomide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This programmable spheroid platform not only recapitulates hallmark features of the GBM immune microenvironment but also uncovers temporally regulated pathways arising from sequential cellular interactions. By enabling controlled reconstruction of dynamic tumor-immune signaling, this system offers a versatile strategy for mechanistic investigation and provides a foundation for evaluating immune-modulatory approaches and microenvironment-targeted interventions in GBM and other malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag151","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:23:19Z","timestamp":1784546599000},"page":"2352-2368","source":"Crossref","is-referenced-by-count":0,"title":["Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor-immune signaling"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6445-5249","authenticated-orcid":false,"given":"Seokgyu","family":"Han","sequence":"first","affiliation":[{"name":"School of Mechanical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3129-8958","authenticated-orcid":false,"given":"Yona","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seoul National University Hospital , Seoul,","place":["Korea"]},{"name":"Cancer Research Institute and Ischemic\/Hypoxic Disease Institute, Seoul National University College of Medicine , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0535-0244","authenticated-orcid":false,"given":"Sein","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1725-1867","authenticated-orcid":false,"given":"Chanyang","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Mechanical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5716-9317","authenticated-orcid":false,"given":"Jaehyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Metabiohealth, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8867-9764","authenticated-orcid":false,"given":"Min-Hyeok","family":"Kim","sequence":"additional","affiliation":[{"name":"School of Mechanical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-1028","authenticated-orcid":false,"given":"Hyo Eun","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seoul National University Hospital , Seoul,","place":["Korea"]},{"name":"Cancer Research Institute and Ischemic\/Hypoxic Disease Institute, Seoul National University College of Medicine , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-5421","authenticated-orcid":false,"given":"Sarnai","family":"Amartumur","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-5425","authenticated-orcid":false,"given":"Chaejeong","family":"Heo","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-8653","authenticated-orcid":false,"given":"Sun Ha","family":"Paek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Seoul National University Hospital , Seoul,","place":["Korea"]},{"name":"Cancer Research Institute and Ischemic\/Hypoxic Disease Institute, Seoul National University College of Medicine , Seoul,","place":["Korea"]},{"name":"Clinical Research Institute, Seoul National University Hospital , Seoul,","place":["Korea"]},{"name":"Advanced Institute of Convergence Technology, Seoul National University , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-1302","authenticated-orcid":false,"given":"Sungsu","family":"Park","sequence":"additional","affiliation":[{"name":"School of Mechanical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]},{"name":"Department of Biomedical Engineering, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]},{"name":"Department of Metabiohealth, Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]},{"name":"Department of Biophysics, Institute for Quantum Biophysics (IQB), Sungkyunkwan University (SKKU) , Suwon,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2026100502520046500_noag151-B1","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: a review on the impact of treatment modalities","volume":"18","author":"Delgado-L\u00f3pez","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"2026100502520046500_noag151-B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.bbcan.2017.05.007","article-title":"Microglia-glioblastoma interactions: new role for wnt signaling","volume":"1868","author":"Matias","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026100502520046500_noag151-B3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab Invest"},{"key":"2026100502520046500_noag151-B4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s13402-020-00523-7","article-title":"Functional and metabolic targeting of natural killer cells to solid tumors","volume":"43","author":"Wang","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"2026100502520046500_noag151-B5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/01.jnen.0000248549.14962.b2","article-title":"Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival","volume":"65","author":"Mizoguchi","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026100502520046500_noag151-B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-012-0981-6","article-title":"The role of STAT3 activation in modulating the immune microenvironment of GBM","volume":"110","author":"See","year":"2012","journal-title":"J Neurooncol"},{"key":"2026100502520046500_noag151-B7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity"},{"key":"2026100502520046500_noag151-B8","doi-asserted-by":"publisher","first-page":"1321318","DOI":"10.3389\/fonc.2023.1321318","article-title":"Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine","volume":"13","author":"Minnar","year":"2023","journal-title":"Front Oncol"},{"key":"2026100502520046500_noag151-B9","doi-asserted-by":"publisher","first-page":"200951","DOI":"10.1016\/j.omton.2025.200951","article-title":"Mitigating IL-12-induced toxicities: a path forward with TNF inhibition","volume":"33","author":"Davydova","year":"2025","journal-title":"Mol Ther Oncol"},{"key":"2026100502520046500_noag151-B10","doi-asserted-by":"publisher","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026100502520046500_noag151-B11","doi-asserted-by":"publisher","first-page":"1183059","DOI":"10.3389\/fonc.2023.1183059","article-title":"Glioblastoma-on-a-chip construction and therapeutic applications","volume":"13","author":"Xie","year":"2023","journal-title":"Front Oncol"},{"key":"2026100502520046500_noag151-B12","doi-asserted-by":"publisher","first-page":"e00093","DOI":"10.1016\/j.bprint.2020.e00093","article-title":"An overview of extrusion-based bioprinting with a focus on induced shear stress and its effect on cell viability","volume":"20","author":"Boularaoui","year":"2020","journal-title":"Bioprinting"},{"key":"2026100502520046500_noag151-B13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.molmed.2023.01.002","article-title":"Modeling glioblastoma complexity with organoids for personalized treatments","volume":"29","author":"Pawlowski","year":"2023","journal-title":"Trends Mol Med"},{"key":"2026100502520046500_noag151-B14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4161\/cc.5.7.2624","article-title":"Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions","volume":"5","author":"Gottfried","year":"2006","journal-title":"Cell Cycle"},{"key":"2026100502520046500_noag151-B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1039\/c0an00609b","article-title":"High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array","volume":"136","author":"Tung","year":"2011","journal-title":"Analyst"},{"key":"2026100502520046500_noag151-B16","doi-asserted-by":"publisher","first-page":"32087","DOI":"10.1021\/acsami.3c02439","article-title":"Multi-Inlet spheroid generator for high-throughput combinatorial drug screening based on the tumor microenvironment","volume":"15","author":"Han","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"2026100502520046500_noag151-B17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1006\/nbdi.2001.0437","article-title":"Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines","volume":"8","author":"Nagai","year":"2001","journal-title":"Neurobiol Dis"},{"key":"2026100502520046500_noag151-B18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/neuonc\/nos268","article-title":"Relationship of glioblastoma multiforme to the subventricular zone is associated with survival","volume":"15","author":"Jafri","year":"2013","journal-title":"Neuro Oncol"},{"key":"2026100502520046500_noag151-B19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40478-021-01156-z","article-title":"Macrophages and microglia: the cerberus of glioblastoma","volume":"9","author":"Buonfiglioli","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2026100502520046500_noag151-B20","doi-asserted-by":"publisher","first-page":"1098482","DOI":"10.3389\/fcell.2023.1098482","article-title":"Roles of STAT3 in the pathogenesis and treatment of glioblastoma","volume":"11","author":"Fu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"2026100502520046500_noag151-B21","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41467-019-11614-x","article-title":"A STAT3-based gene signature stratifies glioma patients for targeted therapy","volume":"10","author":"Tan","year":"2019","journal-title":"Nat Commun"},{"key":"2026100502520046500_noag151-B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2017.01.004","article-title":"The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment","volume":"451","author":"Chang","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2026100502520046500_noag151-B23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-015-1529-6","article-title":"Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors","volume":"131","author":"Brandenburg","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2026100502520046500_noag151-B24","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s00262-021-02897-5","article-title":"Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies","volume":"70","author":"Bareham","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"2026100502520046500_noag151-B25","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.3390\/cancers14194802","article-title":"Microglia-based gene expression signature highly associated with prognosis in low-grade glioma","volume":"14","author":"Schaafsma","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026100502520046500_noag151-B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cytogfr.2014.11.003","article-title":"NK cells and interferons","volume":"26","author":"Paolini","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026100502520046500_noag151-B27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2017.00304","article-title":"Type I interferons and natural killer cell regulation in cancer","volume":"8","author":"Muller","year":"2017","journal-title":"Front Immunol"},{"key":"2026100502520046500_noag151-B28","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1007\/s00018-010-0377-8","article-title":"Granzyme B is recovered by natural killer cells via clathrin-dependent endocytosis","volume":"67","author":"Li","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"2026100502520046500_noag151-B29","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br J Cancer"},{"key":"2026100502520046500_noag151-B30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-021-01151-4","article-title":"Perspective of mesenchymal transformation in glioblastoma","volume":"9","author":"Kim","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2026100502520046500_noag151-B31","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"2026100502520046500_noag151-B32","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1038\/s41467-019-11947-7","article-title":"Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"key":"2026100502520046500_noag151-B33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41597-019-0131-5","article-title":"Deep single-cell RNA sequencing data of individual T cells from treatment-naive colorectal cancer patients","volume":"6","author":"Zhang","year":"2019","journal-title":"Sci Data"},{"key":"2026100502520046500_noag151-B34","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/neuonc\/noaf113","article-title":"Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap","volume":"27","author":"Ruiz-Moreno","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026100502520046500_noag151-B35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro Oncol"},{"key":"2026100502520046500_noag151-B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"2026100502520046500_noag151-B37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014a target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2026100502520046500_noag151-B38","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3389\/fimmu.2017.01970","article-title":"Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands","volume":"8","author":"Metzemaekers","year":"2017","journal-title":"Front Immunol"},{"key":"2026100502520046500_noag151-B39","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1039\/d5lc00359h","article-title":"ECM-integrated hanging drop platform for spatially controlled assessment of immune cell regulated tumour invasion","volume":"25","author":"Lee","year":"2025","journal-title":"Lab Chip"},{"key":"2026100502520046500_noag151-B40","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ncb3429","article-title":"Tissue mechanics promote IDH1-dependent HIF1\u03b1\u2013tenascin C feedback to regulate glioblastoma aggression","volume":"18","author":"Miroshnikova","year":"2016","journal-title":"Nat Cell Biol"},{"key":"2026100502520046500_noag151-B41","doi-asserted-by":"publisher","first-page":"Cns87","DOI":"10.2217\/cns-2022-0005","article-title":"A first-in-human phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma","volume":"11","author":"Groot","year":"2022","journal-title":"CNS Oncol"},{"key":"2026100502520046500_noag151-B42","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1038\/onc.2017.261","article-title":"Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas","volume":"36","author":"Yan","year":"2017","journal-title":"Oncogene"},{"key":"2026100502520046500_noag151-B43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cancers13030437","article-title":"The role and therapeutic targeting of JAK\/STAT signaling in glioblastoma","volume":"13","author":"Ou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026100502520046500_noag151-B44","doi-asserted-by":"publisher","first-page":"eadj3301","DOI":"10.1126\/sciadv.adj3301","article-title":"Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival","volume":"10","author":"Haley","year":"2024","journal-title":"Sci Adv"},{"key":"2026100502520046500_noag151-B45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol Cancer"},{"key":"2026100502520046500_noag151-B46","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural killer cells at the frontline in the fight against cancer","volume":"15","author":"Co\u00ebnon","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026100502520046500_noag151-B47","doi-asserted-by":"publisher","first-page":"eabl4106","DOI":"10.1126\/scitranslmed.abl4106","article-title":"Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models","volume":"14","author":"Birocchi","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026100502520046500_noag151-B48","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3389\/fimmu.2019.02683","article-title":"CAR-engineered NK cells for the treatment of glioblastoma: turning innate effectors into precision tools for cancer immunotherapy","volume":"10","author":"Burger","year":"2019","journal-title":"Front Immunol"},{"key":"2026100502520046500_noag151-B49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat Neurosci"},{"key":"2026100502520046500_noag151-B50","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"2026100502520046500_noag151-B51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12943-025-02479-4","article-title":"Advances in engineering immune\u2013tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery","volume":"24","author":"Dabbagh Moghaddam","year":"2025","journal-title":"Mol Cancer"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag151\/69696700\/noag151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2352\/69696700\/noag151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2352\/69696700\/noag151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:06Z","timestamp":1791183126000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/10\/2352\/8739207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag151","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,21]]}}}